Aren't American drugs expensive because the market will bear almost any expense? Privatised healthcare with a heavily segmented insurance market sort of has that effect. In the UK, the NHS is very strict about what they will pay for drugs. You can buy some drugs on a private prescription, but they will cost a lot more than the subsidised £9.90 you pay for a standard prescription in the UK.
I was a bit curious about the prices of certain weight loss drugs, because some podcast was talking about it. It's all the rage in Hollywood now. So it's something like 70 EUR in Europe, 1300 USD in the US. This is per month.
You know, he is right. It's wild-west capitalism, and shouldn't cost that much. And this is just one example, there are several where a life-saving drug is sold at prices that bankrupt people.
Government steps in and regulates the prices, everyone goes crazy because "muh freedom" and takes the side of big pharma. Against some poor chap who needs insulin to stay alive because big food sold him kilograms of sugar.
Yeah, I agree, T is actually right about this. Stopped clocks and all. But, I wonder how the US will regulate drug prices when a drug is only sold in the US, or only in a limited market. There are also lots of variations on drugs, maybe one market has approved pills and another has approved injection, but the drug is fundamentally identical, that could create pricing discrepancy if it is of benefit to the pharmaceutical firms to manipulate the market in that way. Because they will want to keep their golden goose.
I did see a proposal of a drug funding system that would move away from the likes of Martin Shkreli and the wild west. Basically, drugs should be 'tendered' a bit like a competitive process. European Medicines Authority or whomever it is puts a proposal forward saying, "we would like a drug that substantially cures the side effects of type 2 diabetes, it should do this, it should be compatible in 99% of the diabetic type-2 population, it should have no worse side effects than <list>, it should cost no more than 5 euros per dose to manufacture" and so on. Drug companies would then receive a large amount if they submit a successful drug after it had been tested by the authorities. The amount would be on the order of billions of euros for some drugs, reflecting the high cost of research and development and the high risks taken. But, the drug would then become the property of the state. They could charge 1 euro for each dose if they wanted. Other countries could choose to participate in a marketplace like this, but only by contributing that initial funding would they gain rights to those drugs. EMA could give away drugs with humanitarian benefit too. Suddenly, a drug that had limited commercial opportunity, like a drug to cure AIDS, as a hypothetical, might be funded where it would not otherwise have been commercially viable to do so.
It sounded like a good proposal, and far better than the existing system, but I have no idea if anyone is thinking seriously about changing the marketplace in this way.